1. Home
  2. FTW vs AUTL Comparison

FTW vs AUTL Comparison

Compare FTW & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FTW

EQV Ventures Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$12.40

Market Cap

470.2M

Sector

Energy

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.66

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTW
AUTL
Founded
N/A
2014
Country
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.2M
433.8M
IPO Year
2024
2025

Fundamental Metrics

Financial Performance
Metric
FTW
AUTL
Price
$12.40
$1.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
89.6K
1.4M
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.33
EPS
N/A
N/A
Revenue
N/A
$10,120,000.00
Revenue This Year
N/A
$670.78
Revenue Next Year
N/A
$80.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
496.00
52 Week Low
$10.40
$1.11
52 Week High
$13.75
$2.70

Technical Indicators

Market Signals
Indicator
FTW
AUTL
Relative Strength Index (RSI) 76.60 55.47
Support Level N/A $1.65
Resistance Level N/A $1.69
Average True Range (ATR) 0.61 0.11
MACD 0.20 0.03
Stochastic Oscillator 57.81 51.99

Price Performance

Historical Comparison
FTW
AUTL

About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares

EQV Ventures Acquisition Corp is a blank check company.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: